Displaying 709 - 720 items out of 723 results
Press release
… Hospital, St Leonards, Australia, 4Petrov Scientific Research Oncology Institute, St- Petersburg, Russian … owns stocks in and has taken part in company-sponsored research for Genentech. A. Zeaiter: Employee of F. Hoffman-La …
ILCN article
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …
ILCN article
2024 IASLC Academy to Once Again Compete in Amazing Case Race
… group of early career thoracic oncology clinicians and researchers has been a wonderful experience,” he said. …
Press release
… as well as a principal investigator in health services research and AI. Dr. Moraes is an active member of the IASLC …
Press release
… access, particularly for those at highest risk. The researchers concluded that further evaluation of specific …
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …
Press release
… collaborative approaches to raising awareness, education, research, and partnerships. We are privileged to have such a …
Press release
… thoracic malignancies. IASLC also publishes JTO Clinical Research Reports , an open-access publication. Visit …
Press release
… MD, FRCP, Postgraduate Institute of Medical Education and Research (India). Corporations currently participating in …
Press release
… to reduce the disparity of treatment outcome. Further research is warranted to develop policies and guidelines to …
Press release
… other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 …
ILCN article
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …